genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
AAV (Adeno-associated virus)
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
Coronavirus
Rough Surf Ahead for California
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
News
Drug Discovery
Targeted Protein Degradation Represents a Promising Therapeutic Strategy
Stem Cells
Stem Cell Discovery Could Point to New Strategies for Glaucoma Therapy
Coronavirus
NIH Invests $248.7 Million to Ramp up COVID-19 Testing
OMICs
Sickle Cell Disease Complications Triggered by Gut Microbiome
Cancer
Critical Recurring Mutation Identified in Head and Neck Cancers
Insights
All
Trends for 2020
Bioprocessing
Standardizing Cell and Gene Therapy Remains Bioindustry Goal
Bioprocessing
COVID-19 Increases Demand for Next-Generation Bioprocessing Technology
Bioprocessing
Moving Quickly but Smartly from R&D to Commercialization
August 2020 Vol. 40 No. 8
Fully Automated Luxury Drug Discovery
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Drug Discovery
Targeted Protein Degradation Represents a Promising Therapeutic Strategy
Bioprocessing
Standardizing Cell and Gene Therapy Remains Bioindustry Goal
Bioprocessing
COVID-19 Increases Demand for Next-Generation Bioprocessing Technology
Bioprocessing
Moving Quickly but Smartly from R&D to Commercialization
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Tutorial
In-Depth GPCR Signaling Characterization for Improved Drug Discovery
New Products
Precoated Plates
New Products
Liquid Chromatograph Mass Spectrometer
New Products
RNA Quantification Assay
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Antibodies
Antibody Drug Conjugates
Antibody Drug Conjugates
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Antibody Drug Conjugates
AstraZeneca, Daiichi Sankyo Target TROP2 in Up-to-$6B Cancer Collaboration
Commentary
Overcoming Challenges in the Development of Anticancer ADCs
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Antibody Drug Conjugates
Recent Advances and the Future of Antibody Engineering
Antibody Drug Conjugates
AstraZeneca, Daiichi Sankyo Launch Potentially $6.9B+ Collaboration to Develop Cancer ADC
Webinars
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
Antibody Drug Conjugates
Catalent Invests $200M in Fast-Growing Biologics Manufacturing Business
Antibody Drug Conjugates
Bacterial Persister Cells Sleep with One Eye Open to Foil Immune...
Antibody Drug Conjugates
Pfizer Ends CytomX “Probody” Cancer Collaboration
Antibody Drug Conjugates
Magenta, Heidelberg Pharma Launch Bone Marrow Transplant ADC Collaboration
Antibody Drug Conjugates
Seattle Genetics, Pieris Launch Up-to-$1.2B Immuno-Oncology Collaboration
Antibody Drug Conjugates
Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...
Antibody Drug Conjugates
Glythera, Iontas Launch Cancer ADC Collaboration
Antibody Drug Conjugates
Celgene Ends Option to Buy Sutro, Gains Rights to I/O Candidates...
Antibody Drug Conjugates
Astellas Shutting Agensys Research Operations, Axing 220 Employees in Retreat from...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
